F490S), F490S) Protein. ,Recombinant SARS-Cov-2 Spike RBD protein (L452Q, His (HEK293), Recombinant (His Tag), Recombinant SARS-COV-2 S protein RBD (L452Q, SARS-CoV-2 spike protein, 2019-nCOV Spike protein, Spike glycoprotein, Spike protein S1, Surface glycoprotein, Spike protein RBD, SPIKE_SARS2, 2019-nCOV Spike protein(L452Q, sars-cov-2
Recombinant SARS-Cov-2 Spike RBD protein (L452Q, F490S), His (HEK293), with a concentration of >0.5 mg/ml, expressed in HEK293 cell, with a molecular weight of 36 kDa, and a purity of >90% as determined by SDS-PAGE. It was purified by AC, and has a His tag.
Konzentration:
>0.5 mg/ml
Molekulargewicht:
36 kDa
Reinheit:
>90% as determined by SDS-PAGE
Sequenz:
319-541/1273
Target-Kategorie:
Spike glycoprotein
Anwendungsbeschreibung:
Application Notes: Centrifuge tubes before opening. Reconstituting to a concentration more than 100 µg/ml is recommended. Dissolve the lyophilized protein in distilled water
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: orb1516578) at 2 µg/ml (100 ul/Well) can bind SARS-CoV-2 Spike RBD (L452Q, F490S), His Tag (Cat: orb1516633), the EC50 is 39 ng/ml.
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten